Ultragenyx Pharmaceutical (STU:UP0) Buildings And Improvements : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ultragenyx Pharmaceutical Buildings And Improvements?

Ultragenyx Pharmaceutical's quarterly buildings and improvements increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€166.3 Mil) but then declined from Dec. 2023 (€166.3 Mil) to Mar. 2024 (€0.0 Mil).

Ultragenyx Pharmaceutical's annual buildings and improvements increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€2.6 Mil) and increased from Dec. 2022 (€2.6 Mil) to Dec. 2023 (€166.3 Mil).

Ultragenyx Pharmaceutical Buildings And Improvements Historical Data

The historical data trend for Ultragenyx Pharmaceutical's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultragenyx Pharmaceutical Buildings And Improvements Chart

Ultragenyx Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

2.64

166.30

Ultragenyx Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	166.30	-

Ultragenyx Pharmaceutical Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Ultragenyx Pharmaceutical (STU:UP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultragenyx Pharmaceutical Inc (STU:UP0) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

RARE:USA RARE:Mexico

Address

60 Leveroni Court, Novato, CA, USA, 94949

Website

https://www.ultragenyx.com

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Ultragenyx Pharmaceutical (STU:UP0) Headlines

No Headlines